"Trumpflation" Is Roiling Wall Street -- and It May Not Be a Short-Term Issue as the President Suggests

U.S. inflation has risen to 3.8% TTM in April and is projected to climb another 38 bps to 4.18% in May, driven by tariffs and the energy shock from the Iran conflict. The article warns that a hawkish new Fed chair, Kevin Warsh, could keep policy tight, with CME FedWatch implying a greater-than-77% chance of a rate hike by April 2027. Higher inflation and rates are framed as a major headwind for an expensive equity market, especially the S&P 500, Dow, and Nasdaq.

Analysis

The market is not pricing a simple inflation overshoot; it is pricing a regime shift where higher energy passes through with a lag into corporate margins, wage negotiations, and eventually policy. The most important second-order effect is that the AI capex story becomes rate-sensitive exactly when financing costs are likely to reprice higher, so the biggest beneficiaries of the bull market are also the most exposed to duration compression. That argues for rotating away from the longest-duration growth names and toward businesses with pricing power or explicit volatility benefits.

CME is the cleanest direct beneficiary because higher realized inflation and a more hawkish terminal path both expand the value of rate optionality and trading activity. The market is likely underestimating how quickly the vol surface can steepen if the Fed signals even one additional hike, which tends to support exchange and derivatives volumes before it helps banks or cyclicals. By contrast, NFLX and INTC are more vulnerable on the margins: not because of immediate demand collapse, but because higher discount rates and tighter consumer budgets pressure discretionary spending and capital allocation discipline.

The more interesting trade is that the pain may initially show up in multiple compression rather than earnings recession. If inflation keeps grinding higher into the next two prints, the market can derate 5-10 turns before analysts have time to cut numbers, especially in the most crowded AI beneficiaries. The contrarian point is that the selloff may be sharper in rate-sensitive winners than in the macro losers, because positioning is much more one-sided in growth, and the first leg down is usually a factor unwind rather than a fundamentals washout.

Key Decisions for Investors

• Go long CME vs. short NVDA in a 3-6 month pair trade: CME benefits from higher realized and implied rate volatility, while NVDA is exposed to higher discount rates and AI capex scrutiny; target 15-20% relative outperformance for CME with a tight stop if inflation data rolls over for two consecutive months.
• Reduce net long exposure to mega-cap AI/growth baskets over the next 2-4 weeks and replace with a barbell of cash-generative defensives and vol beneficiaries; the risk/reward is favorable because the downside is multiple compression rather than earnings revision risk.
• Initiate a tactical short in NFLX via put spreads 1-3 months out: consumer budget pressure plus a higher-for-longer rate backdrop should compress discretionary multiples before subscriber metrics visibly weaken; aim for 2-3x premium on a modest downside move.
• Keep a small long in CME as a hedge against an upside inflation surprise; this is one of the few names where a steeper path for rates can improve both volume and volatility monetization.